Prescribed Benzodiazepines and Suicide Risk: A Review of the Literature
The DOI matches its Crossref record.
Abstract
OBJECTIVE: To evaluate whether prescribed benzodiazepines affect one's risk of suicide. DATA SOURCES: A PubMed search of English-language publications from database inception until October 11, 2016, was conducted using the terms benzodiazepine and suicide. References and related articles were also searched to yield additional publications. STUDY SELECTION/DATA EXTRACTION: Studies were included if they addressed the relationship between suicidal behavior and the prescribed use of either specific benzodiazepines or benzodiazepines as a class. A total of 17 studies were included in this review. RESULTS: The majority of studies found that benzodiazepines were associated with increased suicide risk. This finding was consistent across various populations and different types of research, including a placebo-controlled crossover trial, a laboratory model of suicidal behavior, case-control studies regarding completed suicides on inpatient units, and large naturalistic studies. CONCLUSIONS: Benzodiazepines appear to cause an overall increase in the risk of attempting or completing suicide. Possible mechanisms of prosuicidal effects may include increases in impulsivity or aggression, rebound or withdrawal symptoms, and toxicity in overdose.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-term BZD use is associated with an increased risk of physical dependence and withdrawal and ongoing risk of adverse events such as falls, motor vehicle accidents, and cognitive impairment.3,11–13”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [13]
In the citing paper
“Evidence also suggests that use of BZDs is associated with increased suicide risk, although the mechanism for this association is not well understood.12,13”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [13]
In the citing paper
“The dose of BZD given also positively correlated with increased risk of an overdose death [50].”
From Benzodiazepines: Uses, Dangers, and Clinical Considerations (2021) · cites this paper as [50]
In the citing paper
“A study investigating the prescription of opioids and BZD in veterans showed an increased risk of overdose death in veterans who have prescriptions for both BZD and opioids at the same time [50].”
From Benzodiazepines: Uses, Dangers, and Clinical Considerations (2021) · cites this paper as [50]
In the citing paper
“First, BZD have been associated with worse mood outcomes long-term and may increase suicidality in vulnerable patients with other psychiatric risk-factors.141, 142, 143, 144”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cited by
Items 101–144 of 144
Smith, A. M., Acharya, M., Hudson, T. J., Hayes, C. J., Porter, A., Turpin, J., Bona, J. P., Utecht, J., & Martin, B. C. (2022) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2022.12.023 · Cited by 2
Clinical pharmacology of anxiolytics
Bourin, M. (2018) · Archives of Depression and Anxiety · doi:10.17352/2455-5460.000029 · Cited by 2
“The disinhibiting effect can be the cause of sometimes successful suicide attempts [12].”
BackgroundCooper, S. A., Szymanski, B. R., Karel, M., Katz, I., & Mccarthy, J. (2021) · Suicide and Life-Threatening Behaviour · doi:10.1111/sltb.12780 · Cited by 1
Tanahashi, I., Shiganami, T., Iwayama, T., Wake, T., Kobayashi, S., & Yoshimasu, H. (2022) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12242 · Cited by 3
Dutta, R., & Hook, J. (2024) · Cambridge University Press eBooks · doi:10.1017/9781108973922.008 · Cited by 2
Trimm, K., Moraga, M.-T., Knaüper, B., Rahme, E., McDonald, E. G., & Tamblyn, R. (2025) · Clinical Drug Investigation · doi:10.1007/s40261-025-01476-1 · Cited by 3
“Further concern is raised by the association of benzodiazepine use with suicidal impulses [36–38].”
Guidelines for the prevention of suicide and high-risk behaviors
Hadei, N., Yaghoubi, F., Basirat, Z. B., Basirat, A. M. B., & Momeni, J. (2024) · The Neuroscience Journal of Shefaye Khatam · doi:10.61186/shefa.12.4.111 · Cited by 1
Benzodiazepines Safe in Chronic Obstructive Pulmonary Disease? Don’t Hold Your Breath
Koch, A. L., & Paulin, L. M. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201809-618ed · Cited by 1
Alcohol and Sedative Use Disorders and Related Emergencies
Wittmann, C. W., Donovan, A. L., & Nisavic, M. (2019) · Current clinical psychiatry · doi:10.1007/978-3-319-23961-3_2 · Cited by 1
What Is Suicidal Behavior, and Can It Be Prevented?
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.002
“In my end is my beginning”: A Neurodevelopmental Perspective on Suicidal Behavior*
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.008
I Predict, Therefore I Cannot Be: A Predictive Coding Account of Suicidal Behavior
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.009
Predicting the Unpredictable: Neuroscience Contributions to Suicide Prediction
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.010
The Dark Side of the Brain: Neuroscience Approaches to Suicidal Behavior
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.004
Welche legalen Drogen machen süchtig?
Yesil, N. A. (2021) · Springer eBooks · doi:10.1007/978-3-662-62490-6_3
The Treatment of Suicide Risk: Neuroscience Aspects
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.011
Images of the Suicidal Brain: Systems Neuroscience and Suicide
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.007
I Think, Therefore I Do Not Want to Be: The Cognitive Neuroscience of Suicidal Behavior
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.006
The Role(s) of Psychopharmacology in the Treatment of PTSD
Baig, M. R., & Roache, J. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00150-x · Cited by 1
(2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.013
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.015
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.001
Lethal Signals: The Molecular Neuroscience of Suicidal Behavior
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.005
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.012
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.014
Colón-Rivera, H., Aoun, E. G., & Vaezazizi, L. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75486-6.00005-9
PRACTICE TESTS ANSWER KEY (CHAPTER 14)
(2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75486-6.00025-4
Causes and Risk Factors of Suicide among Adolescents and Youth in India: a Review
-, A. A. (2023) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2023.v05i01.1529 · Cited by 1
Médicaments détournés de leur usage
Victorri‐Vigneau, C., & Fatseas, M. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77934-3.00023-8
Depressive Erkrankungen in der hausärztlichen Versorgung
Biersack, K. (2024) · Zeitschrift für Allgemeinmedizin · doi:10.1007/s44266-024-00268-8
“…und unbedingt zeitlich begrenzte Einsatz von Benzo-diazepinen empfohlen [2]; kurzzeitig und überwacht, weil diese Medikamentenklasse bei längerer Einnahme durch Sucht-und Ent-zugsgefahr ein Risiko für Suizidalität darstellt und sogar als Mittel der Selbsttötung eingesetzt werden kann [22].”
Benzodiazepine Addiction: A Difficult Story
Bourin, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-72219-6_17
Laurin, A., Artarit, P., Vanhille, J.-L., Bulteau, S., Sauvaget, A., Fanton, L., & Nohales, L. (2025) · European Journal of Trauma & Dissociation · doi:10.1016/j.ejtd.2025.100517
Uso de benzodiazepínicos como fator de risco para o comportamento suicida: uma revisão integrativa
Coimbra, T. F., Mendonça, M. D. B., Maslinkiewicz, A., Chaparro, M., de Oliveira, H. M., de Lira, K. R. B., Dondoni, C. M., Rodrigues, R., Ferreira, A. P., Ferreira, P. D. S., et al. (2025) · Caderno Pedagógico · doi:10.54033/cadpedv22n10-182
Okasha, T. A., Fekry, M., Naguib, R. M., Masry, S. H. A. E., & Tawfik, F. A. (2025) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-025-01052-6 · Cited by 1
“Furthermore, 40.6% of patients in the study reported BZD use, previous research has shown that 54% of patients who were using, reducing, or discontinuing BZD, reported experiencing suicidal ideations [25].”
InfluentialSupporting depression care: antidepressant prescribing patterns among adults in Alberta, Canada
Ofosu, N. N., Jabbour, B., Setchell, B., Mathe, N., Ross, D. A., & Campbell-Scherer, D. (2026) · BMC Family Practice · doi:10.1186/s12875-026-03190-z
“Findings from a scoping review that examined the role of BZRAs in clinical practice guidelines globally [17], also supports the general trend of regulating BZRAs, including restrictions for short-term use due to potential for harm and dependence [18, 19].”
Cost-utility analysis of benzodiazepine deprescription in primary care: a cohort study
López, I. F., Špacírová, Z., Lima, A. O. D. L., Gutierrez-Valencia, A., Sayago, M. F., Celdran, M. M., Bernal, M. A. S., & Bermúdez‐Tamayo, C. (2026) · BMC Health Services Research · doi:10.1186/s12913-026-14149-2 · Cited by 1
“In severe cases, long-term use has been linked to elevated suicide risk, while abrupt discontinuation can precipitate serious withdrawal complications such as delirium and seizures [4–6].”
Ameliorative effects of Saussurea lappa against hypertension and anxiety in animal models
Gaur, A., Mazumder, A., Das, S., Raghuvanshi, S., & Sinha, A. (2026) · Indian Journal of Physiology and Pharmacology · doi:10.25259/ijpp_290_2025
Biologische interventies bij suïcidaliteit
Tonies, L., & van Veen, S. M. P. (2026) · doi:10.1007/978-90-368-3172-7_10
Jarratt, C. J., Carlin, V. E., Ripley, G. H., Nam, J. K., Marfilius, K. J., & Ditre, J. W. (2026) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2026.2685519
Multicenter toxicological analysis of psychoactive substances in suicide victims in Brazil
Bombana, H. S., Castaldelli-Maia, J. M., Takitane, J., Carvalho, H. B., Wang, Y., Miziara, I. D., Yonamine, M., & Leyton, V. (2026) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-026-01324-4
Pinzi, M., Cuomo, A., Rescalli, M. B., Pierini, C., & Fagiolini, A. M. (2026) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2026.2714839
“Benzodiazepines may provide short-term anxiolysis or sedation but do not address the broader cognitive and affective processes associated with suicidality and carry risks of dependence, disin-hibition, and misuse [11].”
Psychiatric Severity and Resilience in Outpatients Seeking Treatment for Cocaine Use Disorder
Bochereau, J., Karsinti, E., Bloch, V., Zerdazi, E., Belforte, B., Moisan, D., Deschenau, A., Cottencin, O., Gay, A., Lack, P., et al. (2026) · Journal of Dual Diagnosis · doi:10.1080/15504263.2026.2726791
“Benzodiazepine use disorders have long been associated with history of suicide attempts (Dodds, 2017; Icick et al., 2018; Rissanen et al., 2015), including in samples with severe multiple addictions.”
Collins, E., Liu, J. J. W., Bilodeau, M., Burhan, A. M., Enns, M. W., Lavoie, V., Ein, N., Nazarov, A., Auger, É., Balderson, K., et al. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1931305
Кибитов, А. А., & Ma, M. (2026) · Psikhiatriya · doi:10.30629/2618-6667-2026-24-4-28-39
Metadata
- Authors
- Dodds, T. J.
- Affiliations
- Austen Riggs Center (US)
- Corresponding author
- Dodds, Tyler J.
- ORCID
- Dodds, Tyler J.
- Venue
- The Primary Care Companion For CNS Disorders
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2017-03-02
- Volume
- 19
- Issue
- 2
- ISSN
- 2155-7772 (ISSN-L)
- 2155-7780
- OpenAlex
- W2592924765
- Cited by
- 144
- References
- 0
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 14 · 2023: 12 · 2022: 14 · 2021: 23 · 2020: 19 · 2019: 13 · 2018: 27 · 2017: 1
- FWCI
- 20.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Primary Care Companion For CNS Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- benzodiazepines, suicide risk, suicidal behavior, suicide attempts, suicide completion, impulsivity, benzodiazepine overdose
- MeSH terms
- Benzodiazepines, Humans, Risk, Suicide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.